Becton Dickinson (NYSE:BDX) received FDA clearance for its Surgiphor 1000mL antimicrobial irrigation system, expanding its surgical solutions portfolio. The company also launched the BD Vacutainer ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained ...

Becton Dickinson (NYSE:BDX) has received FDA 510(k) clearance for its Surgiphor 1000mL antimicrobial irrigation system. The ...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it received ...

Surgiphor 1,000mL allows clinicians to remove debris and microorganisms from wounds during powered irrigation procedures.

BDX wins FDA 510(k) clearance for Surgiphor 1000mL antimicrobial irrigation system, expanding its surgical irrigation portfolio with a powered lavage option.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has obtained CE Marking for the Revello™ Vascular Covered Stent, a next-generation ...

BD wins CE Mark for its Revello vascular covered stent for iliac artery disease, expanding its peripheral vascular portfolio ...

BD (Becton, Dickinson and Company) announced it has obtained CE Mark approval for the Revello vascular covered stent for the ...

The medical technology company’s $100,000 donation expands assistance available to undergraduate and graduate students facing unexpected emergencies.

STOCKHOLM, SE / ACCESS Newswire / March 5, 2026 / Vicore Pharma Holding AB , unlocking the potential of a novel class of drugs, angiotensin II type 2 receptor agonists (ATRAGs), today announced the ...